Wellness Franchise Opportunities

stake Jan, 11 2017

Sequoia and CDC Group to pick up control on Sresta Natural Bioproducts

The investment in Sresta would be attractive for CDC, which is a finance institution focused on sustainable development, as it aims to improves the livelihoods of Indian farmers giving them better pricing power.

By Franchise India Bureau
Sequoia and CDC Group to pick up control on Sresta Natural Bioproducts

Venture capital fund Sequoia Capital and UK government-owned CDC Group are close to picking up a controlling stake in the country’s largest organic food maker Sresta Natural Bioproducts, which sells the 24 Mantra brand, multiple people familiar with the matter said.

The deal, which is in final stages, is expected to give Sequoia and CDC, who are bidding jointly, around 70-80 percent stake in the Hyderabad-based company for nearly USD100 million or Rs 680 crore, sources said.

Existing investors Peepul Capital and Ventureast are likely to exit the company by selling their stakes, another person familiar with the development said. They collectively own about 70 percent in Sresta with the rest of it being held by founder Rajashekar Reddy Seelam.

Sources said the company had earlier approached leading Indian and international food companies such as ITC, Dabur, Global Consumer Products, HUL and Danone, however, those talks were preliminary in nature.

Raj Seelam said, "We do not comment on speculative news." Financial advisory firm Alvarez and Marsal was hired by Sresta to find a buyer last year, but with most strategics having passed the deal citing the nascent organic market and a supply chain that’s still evolving, sources said it is likely to be a financing round.

Another source said, "Right now there are competing offers from financial investors and a foreign strategic. The deal is expected to close by next month or latest by March."

The investment in Sresta would be attractive for CDC, which is a finance institution focused on sustainable development, as it aims to improves the livelihoods of Indian farmers giving them better pricing power. The company’s revenue is estimated at around Rs 200 crore, out of which Rs 60 crore is in sales from international markets like the US and UK where the brand is sold in ethnic stores.

Related: How ISO certification to Indus Health Plus may help in finding right delivery partners

Click Here to add Comment
Please add your Comment
Rating
Sell Business 2017
Sell Franchise 2017

Newsletter Signup

Submit your email address to receive the latest updates on news & host of opportunities from Wellness India.

Video

Magazines & Books

Read the latest franchising magazines and books to get comprehensive and up-to-date information on leading franchise systems, trends and more.


Newsletter Signup
Submit your email address to receive the latest updates on news & host of opportunities.
Well Ness India

Copyright © 2009 - 2017 Franchise India Holdings Ltd.

The information contained herein is of generic nature only, and Franchise India is not, by means of this website or any part thereof, rendering professional advice or services. Before making any decision or taking any action that might affect your finances or business, you should consult a qualified professional advisor. Your use of this website or any of its pages or links given, is at your own risk and you assume full responsibility and risk of loss resulting from your usage. With respect to use of the website, kindly visit www.franchiseindia.com/terms.